Jean Jacques Bienaime - 07 Nov 2023 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Sandra Stoneman, Attorney-in-fact
Issuer symbol
IMNM
Transactions as of
07 Nov 2023
Net transactions value
$0
Form type
4
Filing time
09 Nov 2023, 16:25:27 UTC
Previous filing
12 Dec 2023
Next filing
22 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +40,696 $0.000000 40,696 07 Nov 2023 Common Stock 40,696 $8.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 12 quarterly installments over three years, commencing on November 7, 2023 and continuing thereafter on the same day of each succeeding fiscal quarter, subject to continued service with the Company on each respective vesting date.